Magnetic resonance imaging evaluation of subarachnoid hemorrhage in rats and the effects of intracisternal injection of papaverine and nitroglycerine in the management of cerebral vasospasm

Neurology India
Shashank R RamdurgBhavani S Sharma

Abstract

Cerebral vasospasm is a major cause of morbidity and mortality after subarachnoid hemorrhage (SAH). It usually occurs about 3-9 days after SAH. The pathogenesis involves the release of endogenous spasmogens. Though various treatment modalities are available, none are really effective. The aim of the study was to develop an effective animal model for the study of SAH and vasospasm as well as to study the efficacy of vasodilators, namely nitroglycerine and papaverine, on SAH-induced vasospasm using magnetic resonance angiography. Fifteen Wistar albino rats, weighing around 150-200 gm were used for the study. Five rats served as controls of SAH-induced vasospasm, while five rats each were used to study the efficacy of intracisternal injection of papaverine or nitroglycerine. Rats demonstrate vasospasm in a manner similar to humans. The maximal vasospasm is seen in the basilar artery. Statistical analysis demonstrates an improvement in vasospasm after instillation of intracisternal papaverine at the end of 2 hours in basilar and left internal cerebral artery. However, nitroglycerine does not produce any significant amelioration of vasospasm. Thus, it can be deduced that the pathogenesis of the vasospasm is more due to the action of...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·R L Macdonald, B K Weir
Jan 1, 1968·Journal of Neurosurgery·B W BrawleyW A Kelly
Jul 1, 1982·Stroke; a Journal of Cerebral Circulation·S J PeerlessI G Hunter
May 1, 1995·Pharmacology & Therapeutics·D A Cook
Aug 4, 1998·Journal of Neurosurgery·E W WolfJ T Robertson
Apr 13, 2002·Japanese Journal of Pharmacology·Richard SercombePhilippe Gomis
Oct 18, 2002·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Hon-Man Liu, Yong-Kwang Tu
Feb 8, 2003·Stroke; a Journal of Cerebral Circulation·Cecil O BorelLaura Niklason
May 19, 2005·Acta neurochirurgica·W M van den BerghG J E Rinkel

❮ Previous
Next ❯

Citations

Jul 24, 2013·Neurology Research International·Michael SiutaJ Mocco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.